Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study
- PMID: 17313501
- DOI: 10.1111/j.1572-0241.2007.01080.x
Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study
Abstract
Objective: Dyspepsia is common, and the condition is often chronic, with a relapsing and remitting nature. Factors influencing the decision to consult a physician with symptoms remain unclear.
Methods: The authors conducted a 10-yr follow-up longitudinal survey of individuals originally involved in a community-screening program for Helicobacter pylori (H. pylori). All surviving, traceable participants were contacted by validated postal dyspepsia questionnaire. Baseline demographic data, dyspepsia and irritable bowel syndrome (IBS) symptom data, and quality of life at study entry were already on file. Consent to examine primary care records was requested, and data regarding nonsteroidal anti-inflammatory drug and aspirin use, and dyspepsia and IBS-related consultations over the 10-yr study period were extracted from these.
Results: Of 8,407 individuals originally involved, 3,266 (39%) gave consent to examination of primary care records. The mean age of included individuals was 55 yr, and 1,467 (45%) were male. 1,738 (53%) had dyspepsia, and 729 (42%) of these consulted a primary care physician as a result. Following multivariate logistic regression, H. pylori infection (odds ratio [OR] 1.76, 99% confidence interval [CI] 1.30-2.39), lower socioeconomic status (OR 1.68, 99% CI 1.02-2.76), frequent (OR 2.61, 99% CI 1.69-4.01) or severe (OR 1.87, 99% CI 0.99-3.52) symptoms, and increasing age (OR per year 1.06, 99% CI 1.0-1.11) were independent risk factors for consultation.
Conclusions: Reasons for consulting a physician with dyspepsia are multifactorial, but H. pylori infection, lower socioeconomic status, frequent or severe symptoms, and increasing age are independent predictors of consultation.
Similar articles
-
Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.Am J Gastroenterol. 2008 May;103(5):1229-39; quiz 1240. doi: 10.1111/j.1572-0241.2007.01740.x. Epub 2008 Mar 26. Am J Gastroenterol. 2008. PMID: 18371141
-
Risk factors for dyspepsia in a general population: non-steroidal anti-inflammatory drugs, cigarette smoking and unemployment are more important than Helicobacter pylori infection.Scand J Gastroenterol. 2006 Feb;41(2):149-54. doi: 10.1080/00365520510024070. Scand J Gastroenterol. 2006. PMID: 16484119
-
The proportion of upper gastrointestinal symptoms in the community associated with Helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. Leeds HELP Study Group.Am J Gastroenterol. 2000 Jun;95(6):1448-55. doi: 10.1111/j.1572-0241.2000.2126_1.x. Am J Gastroenterol. 2000. PMID: 10894577
-
Dyspepsia and Helicobacter pylori.Dig Dis. 2008;26(3):210-4. doi: 10.1159/000121348. Epub 2008 May 6. Dig Dis. 2008. PMID: 18463437 Review.
-
GP management of dyspepsia.Practitioner. 2006 Mar;250(1680):134, 136, 139 passim. Practitioner. 2006. PMID: 16568566 Review. No abstract available.
Cited by
-
Upper gastrointestinal symptoms, psychosocial co-morbidity and health care seeking in general practice: population based case control study.BMC Fam Pract. 2009 Sep 9;10:63. doi: 10.1186/1471-2296-10-63. BMC Fam Pract. 2009. PMID: 19740413 Free PMC article.
-
Functional Dyspepsia: Diagnostic and Therapeutic Approaches.Drugs. 2020 Sep;80(13):1319-1336. doi: 10.1007/s40265-020-01362-4. Drugs. 2020. PMID: 32691294 Review.
-
Research Progress for Probiotics Regulating Intestinal Flora to Improve Functional Dyspepsia: A Review.Foods. 2024 Jan 2;13(1):151. doi: 10.3390/foods13010151. Foods. 2024. PMID: 38201179 Free PMC article. Review.
-
United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia.United European Gastroenterol J. 2021 Apr;9(3):307-331. doi: 10.1002/ueg2.12061. United European Gastroenterol J. 2021. PMID: 33939891 Free PMC article.
-
Insights into the evaluation and management of dyspepsia: recent developments and new guidelines.Therap Adv Gastroenterol. 2018 Oct 30;11:1756284818805597. doi: 10.1177/1756284818805597. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 30397412 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical